Tenax Therapeutics names Timothy Healey as Chief Commercial Officer to lead global commercial strategy.

Tenax Therapeutics appointed Timothy Healey, MBA, as Chief Commercial Officer to oversee its global commercial strategy and prepare for the launch of its drug TNX-103. Healey brings extensive pharmaceutical leadership experience, having led successful drug launches at companies like Eversana and AbbVie. His role is crucial as Tenax advances its Phase 3 cardiopulmonary therapy development, aiming to commercialize levosimendan for pulmonary hypertension treatment. This leadership move positions Tenax to better execute its commercial launch and reach patients effectively.